Opioid receptors and heart resistance to arrhythmogenic factors

Bulletin of Experimental Biology and Medicine

Volumn 138, Issue 2, 2004, Pages 107-112

  Lishmanov, Yu B ^a   Maslov, L N ^b  

^a CARDIOLOGY RESEARCH INSTITUTE   (Russian Federation)

^b TOMSK STATE UNIVERSITY   (Russian Federation)

Author keywords

Arrhythmogenesis; cardiac ischemia reperfusion; Opioid receptors

Indexed keywords

DELTA OPIATE RECEPTOR; EPSILON OPIATE RECEPTOR; OPIATE PEPTIDE; OPIATE RECEPTOR;

ARRHYTHMOGENESIS; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART INFARCTION; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART PROTECTION; NONHUMAN; REGULATORY MECHANISM; REPERFUSION INJURY; REVIEW;

ANIMALIA;

EID: 8844223333     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BEBM.0000048363.84047.10     Document Type: Review

References (32)

1. P. F. Litvitskii, Patol. Fiziol. Eksper. Ter., No. 2, 2-12 (2002).
2. Yu. B. Lishmanov and L. N. Maslov, Opioid Neuropeptides, Stress, and Adaptive Protection of the Heart [in Russian], Tomsk (1994)
3. Yu. B. Lishmanov and L. N. Maslov, Kardiologiya, No. 3, 51-57 (2002).
4. Yu. B. Lishmanov and L. N. Maslov, Patol. Fiziol. Eksper. Ter., No. 1, 2-10 (2003).
5. Yu. B. Lishmanov, L. N. Maslov, A. V. Krylatov, et al., Byull. Eksp. Biol. Med., 135, No. 1, 66-70 (2003).
6. Yu. B. Lishmanov, L. N. Maslov, and K. Rais, Eksper. Klin. Farmakol. 65, No. 4, 71-77 (2002).
7. Yu. B. Lishmanov, N. V. Naryzhnaya, A. V. Krylatov, et al., Izv. Ros. Akad. Nauk. Ser. Biol., No. 6, 720-727 (2003).
8. Yu. B. Lishmanov, E. V. Uskina, A. V. Krylatov, et al., Ros. Fiziol. Zh., 84, No. 4, 363-372 (1998).
9. L. N. Maslov, A. V. Krylatov, and Yu. B. Lishmanov, Eksper. Klin. Farmakol., 62, No. 3, 28-31 (1999).
10. L. N. Maslov, A. V. Krylatov, Yu. B. Lishmanov et al., Ros. Fiziol. Zh., 89, No. 4, 397-408 (2003).
11. L. N. Maslov, A. V. Krylatov, N. V. Naryzhnaya, et al., Ibid. 88, No. 7, 842-850 (2002).
12. L. N. Maslov, Yu. B. Lishmanov, J. Kalo, and L. Ma, Eksper. Klin. Farmakol., 66, No. 5, 59-68 (2003).
13. L. N. Maslov, Yu. B. Lishmanov, and A. V. Krylatov, Byull. Eksp. Biol. Med., 122, No. 7, 25-27 (1996).
14. L. N. Maslov, Yu. B. Lishmanov, A. V. Krylatov, and D. S. Ugdyzhekova, Eksper. Klin. Farmakol., 60, No. 1, 35-37 (1997).
15. L. N. Maslov, Yu. B. Lishmanov, and G. N. Smagin, Ibid., 65 No. 2, 70-75 (2002).
16. L. N. Maslov, D. S. Ugdyzhekova, A. V. Krylatov, and Yu. B. Lishmanov, Ros. Fiziol. Zh., 84, No. 12, 1394-1401 (1998).
17. S. D. Mikhailova, G. I. Storozhakov, N. A. Bebyakova, and T. M. Semushkina, Byull. Eksp. Biol. Med., 124, No. 10, 377-379 (1997).
18. N. V. Solenkova, L. N. Maslov, Yu. B. Lishmanov, et al., Eksper. Klin. Farmakol., 65, No. 1, 30-33 (2002).
19. D. S. Ugdyzhekova, L. N. Maslov, A. V. Krylatov, et al., Ibid. 64, No. 4, 17-20 (2001).
20. I. Baczko, I. Lepran, and J. G. Papp, J. Cardiovasc. Pharmacol., 29, 196-201 (1997).
21. M. J. Curtis, M. K. Pugsley, and M. J. A. Walker, Cardiovasc. Res., 27, No. 5, 703-719 (1993).
22. B. N. Dhawan, F. Cesselin, R. Raghubir, et al., Pharmacol. Rev., 48, No. 4, 567-592 (1996).
23. Y. B. Lishmanov, L. N. Maslov, N. V. Naryzhnaya, and S. W. Tam, Life Sci., 65, No. 1, PL13-PL17 (1999).
24. Y. B. Lishmanov, L. N. Maslov, and D. S. Ugdyzhekova, Clin. Exp. Pharmacol. Physiol., 26, No. 9, 716-723 (1999).
25. Y. B. Lishmanov, L. N. Maslov, D. S. Ugdyzhekova, and G. N. Smagin, Life Sci., 61, No. 3, PL33-PL38 (1997).
26. L. N. Maslov and Y. B. Lishmanov, Int. J. Cardiol., 40, No. 2, 89-94 (1993).
27. L. N. Maslov and Y. B. Lishmanov, Clin. Exp. Pharmacol. Physiol., 22, 812-816 (1995).
28. L. N. Maslov, Y. B. Lishmanov, N. V. Solenkova, et al., Life Sci., 73, No. 7, 947-952 (2003).
29. O. Oldenburg, M. V. Cohen, D. M. Yellon, and J. M. Downey, Cardiovasc. Res., 55, No. 3, 429-437 (2002).
30. R. Pabla and M. J. Curtis, Circ. Res., 77, 984-992 (1995).
31. J. E. J. Schultz, A. K. Hsu, H. Nagase, and G. J. Gross, Am. J. Physiol., 274, H909-H914 (1998).
32. Y. Yue, Q. Qin, M. V. Cohen, et al., Cardiovasc. Res., 55, No. 3, 681-689 (2002).